Document Detail


Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result.
MedLine Citation:
PMID:  8154506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study was designed to investigate whether a subclinical accumulation of fluid in the lung interstitium associated with moderate congestive heart failure interferes with the patient's functional capacity, and whether furosemide treatment can promote reabsorption of the excessive fluid. BACKGROUND: In patients with moderate congestive heart failure, pulmonary overhydration may be detected by chest roentgenography even if therapy is optimized to keep the urinary output normal and to prevent weight gain and dependent edema formation. Removal of the overhydration may help define its significance. METHODS: Patients, whose regimens of digoxin, oral furosemide, and angiotensin-converting enzyme (ACE) inhibitor therapy were kept constant, were randomly allocated to receive ultrafiltration (8 cases) or an intravenous bolus of supplemental furosemide (mean dose: 248 mg; 8 cases). The amount of body fluid removed with each method approximated 1600 mL. Functional performance was assessed with cardiopulmonary exercise tests. RESULTS: Soon after fluid withdrawal by either method, the filling pressures of the two ventricles and body weight were reduced and plasma renin activity, norepinephrine, and aldosterone were augmented. After furosemide administration, hormone levels remained elevated for the next 4 days, and during this period, patients had positive water metabolism, recovery of the elevated ventricular filling pressures, and re-occurrence of lung congestion with no improvement in functional capacity. After ultrafiltration, levels of renin, norepinephrine, and aldosterone fell to below control values within the first 48 hours and water metabolism was equilibrated at a new set point (less fluid intake and diuresis without weight gain). The favorable circulatory and ventilatory adjustments consequent to the reabsorption of lung water improved the functional capacity of these patients. That may also have restored the lung's ability to clear norepinephrine, thus restraining its facilitation of renin release. The improvement continued 3 months after the procedure. CONCLUSIONS: In patients with congestive heart failure the set point of fluid balance is altered in spite of oral furosemide therapy; supplemental intravenous furosemide does not shift the set point, at least not when combined with ACE inhibition. Excessive, although asymptomatic, lung water limits the functional capacity of the patient.
Authors:
P Agostoni; G Marenzi; G Lauri; G Perego; M Schianni; P Sganzerla; M D Guazzi
Related Documents :
6399316 - Effects of brain renin-angiotensin on cardiovascular function and saline intake in awak...
7398136 - Role of the autonomic nervous system in the acute responses to renal artery pressure re...
20036896 - Cardiovascular responses to cold exposure.
1461716 - Lack of effect of intraluminal pressure on renin release from isolated afferent arterio...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of medicine     Volume:  96     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-05-09     Completed Date:  1994-05-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  191-9     Citation Subset:  AIM; IM    
Affiliation:
Instituto di Cardiologia dell'Università degli Studi, Fondazione I Monzino, Istituto G. Sisini, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Chronic Disease
Exercise Test
Female
Furosemide / administration & dosage,  therapeutic use*
Heart Failure / complications,  physiopathology,  therapy*
Hemodynamics / physiology
Humans
Injections, Intravenous
Male
Middle Aged
Pulmonary Edema / etiology,  physiopathology*
Respiratory Function Tests
Time Factors
Treatment Outcome
Ultrafiltration*
Chemical
Reg. No./Substance:
54-31-9/Furosemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inherited diseases of the glomerular basement membrane.
Next Document:  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic find...